Pharmacovigilance Asia 2012

Empowering you with regulatory updates, risk management best practices and audit and inspection tools for safer drugs in Asia

Key benefits of attending:
• Regulatory updates on pharmacovigilance from WHO’s Uppsala Monitoring Center, European Commission, China, India, Taiwan, South Korea, Malaysia and Brunei
• Develop and implement risk management and minimisation plans for improved drug safety
• Prepare for audit and inspection: practical steps to get it right
• Eestablish an early signal detection system for improved drug safety
• Best practices in AE reporting for post-marketing surveillance studies
• Achieve compliance in various country regulations in Asia while meeting global safety requirements

Speakers
Dr. Y K Gupta,Angela On,Dr. Du Wenmin,Mohamad Khalid Haji Zolkipli,Dr. Nguyen Hoang Anh,Prof Paul Lalvani,Jean-Christophe Delumeau,Dr Joy Li and many more.